From Reflection to Implementation: Tailored Clinical Development of a Pembrolizumab Biosimilar Candidate
Björn Capsius, Marija Pesic, Ravil Niyazov, Susanne Pippig, Michael Trieb, Rahul Hole, Sigrid Balser, Andreas Seidl
Springer Nature ·
2026-09-19
· DOI 10.1007/s40259-026-00803-y
The publisher did not provide an abstract — full text is available via the link below.
Björn Capsius, Marija Pesic, Ravil Niyazov, Susanne Pippig, Michael Trieb, Rahul Hole et al. From Reflection to Implementation: Tailored Clinical Development of a Pembrolizumab Biosimilar Candidate. // BioDrugs. – 2026. – DOI: 10.1007/s40259-026-00803-y. – URL: https://doi.org/10.1007/s40259-026-00803-y
Björn Capsius, Marija Pesic, Ravil Niyazov, Susanne Pippig, Michael Trieb, Rahul Hole, Sigrid Balser, & Andreas Seidl (2026). From Reflection to Implementation: Tailored Clinical Development of a Pembrolizumab Biosimilar Candidate. BioDrugs. https://doi.org/10.1007/s40259-026-00803-y
Björn Capsius, et al. “From Reflection to Implementation: Tailored Clinical Development of a Pembrolizumab Biosimilar Candidate.” BioDrugs, 2026. doi:10.1007/s40259-026-00803-y.
@article{Capsius2026,
title = {From Reflection to Implementation: Tailored Clinical Development of a Pembrolizumab Biosimilar Candidate},
author = {Capsius, Björn and Pesic, Marija and Niyazov, Ravil and Pippig, Susanne and Trieb, Michael and Hole, Rahul and Balser, Sigrid and Seidl, Andreas},
journal = {BioDrugs},
year = {2026},
doi = {10.1007/s40259-026-00803-y},
url = {https://doi.org/10.1007/s40259-026-00803-y}
}